Comparison of an assay based on RD1 selected peptides with commercially available assays based on RD1 overlapping peptides to identify subjects with active TB

D. Goletti, S. Carrara, D. Vincenti, O. Butera, F. Bizzoni, M. Amicosante, C. Saltini, E. Girardi (Rome, Italy)

Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis
Session: Genetics and immunobiology of tuberculosis
Session type: Oral Presentation
Number: 272
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Goletti, S. Carrara, D. Vincenti, O. Butera, F. Bizzoni, M. Amicosante, C. Saltini, E. Girardi (Rome, Italy). Comparison of an assay based on RD1 selected peptides with commercially available assays based on RD1 overlapping peptides to identify subjects with active TB. Eur Respir J 2005; 26: Suppl. 49, 272

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
An assay based on RD1 selected peptides for the diagnosis of extra-pulmonary and smear negative tuberculosis
Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Year: 2008

A new immune diagnostic assay based on ESAT-6 and CFP-10 epitopes in the evaluation of subjects with a clinical suspicion of active tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 427s
Year: 2004

The role of a new immuno-diagnostic test based on ESAT-6 epitopes in the screening of subjects with a clinical suspicion of active tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 166s
Year: 2003

Comparison of ELISPOT and whole-blood assays for IFN-gamma in the immune diagnosis of tuberculosis using ESAT-6 and CFP-10 selected peptides
Source: Eur Respir J 2004; 24: Suppl. 48, 206s
Year: 2004

New tools to discriminate active from past tuberculosis: comparison of the response to RD1 antigens vs latency antigens
Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis
Year: 2009

Monitoring of ESAT-6/CFP-10 selected peptides response during prophylaxis in individuals exposed to M. tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 363s
Year: 2006

Negative effect of ferritin levels on T-SPOT.TB, an enzyme-linked immunospot based interferon-gamma release assay using Mycobacterium tuberculosis specific antigens, in the smear-positive active pulmonary tuberculosis.
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018


IFN-gamma production in response to RD1 assays correlate with TST size and with the frequency of exposure to the index case in contacts recently exposed to mycobacterium tuberculosis
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007


Design of immunogenic multiepitopic mycobacterium tuberculosis peptides from genes selected using in vitro models of mycobacterial macrophage infection
Source: Eur Respir J 2007; 30: Suppl. 51, 493s
Year: 2007

Evaluation of rapid test device based on detection of antibodies against 6,16 and 38 kDa antigens of mycobacterium tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009


Pre-clinical study of specific activity and specificity of recombinant diagnostic preparation DIASKINTEST based on proteins ESAT-6 and CFP10 in guinea-pigs infected with M. tuberculosis
Source: Annual Congress 2010 - Scientific advances in tuberculosis
Year: 2010

Comparison of whole-blood interferon-gamma release assay and tuberculin skin test results for the prediction of active tuberculosis disease in HIV-infected individuals
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009


Comparative evaluation of the rapid diagnostic assays for detecting tuberculosis (TB) in a reference center for drug resistant TB in Brazil
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020


Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009


Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008


IFN-gamma response on T-cell based assays in HIV patients for detection of tuberculosis infection
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008

Sequential analysis of interferon-γ release assay results in active tuberculosis patients
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009


Improved performances of the Quantiferon-TB in tube assay with novel mycobacterium tuberculosis specific antigenic peptides
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013



A set of microRNA markers of active tuberculosis.
Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis
Year: 2020


Evaluation of TB antibodies using ELISA and M. tuberculosis DNA using PCR in children and adolescents from high-prevalence regions
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008